NeuroBo Pharmaceuticals I... (NRBO)
NASDAQ: NRBO
· Real-Time Price · USD
2.36
null (null%)
At close: Nov 27, 2024, 10:00 PM
NeuroBo Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 20K | 20K | 20K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 10K | 16K | 20K | 14K | 15K | 9K | 6K | 3K | 4K | 11K | 22K | 57K | 67K | 60K | 48K | 12K | n/a | n/a |
Gross Profit | 10K | 4K | n/a | -8K | -9K | -3K | n/a | -3K | -4K | -11K | -22K | -57K | -67K | -79K | -84K | -48K | -36K | -17K |
Operating Income | -20.03M | -25.81M | -28.81M | -28.89M | -26.52M | -20.25M | -15.89M | -12.44M | -11.65M | -11.06M | -11.42M | -13.78M | -14.14M | -14.84M | -15.3M | -30.23M | -29.83M | -28.3M |
Interest Income | 793K | 811K | 920K | 1.01M | 862K | 698K | 461K | 164.19K | 2.19K | 2.19K | 2.19K | 14K | 17K | 22K | 28K | 14K | 11K | 6K |
Pretax Income | -18.49M | -24.55M | -27.59M | -27.73M | -25.9M | -16.58M | -12.47M | -11.83M | -11.13M | -13.7M | -13.97M | -13.87M | -14.22M | -14.84M | -15.28M | -30.22M | -29.81M | -28.27M |
Net Income | -18.49M | -24.55M | -27.59M | -27.73M | -25.9M | -16.58M | -12.47M | -6.16M | -5.47M | -8.04M | -8.31M | -13.88M | -14.22M | -14.84M | -15.28M | -30.22M | -29.81M | -28.27M |
Selling & General & Admin | 6.82M | 6.84M | 7.26M | 7.52M | 7.38M | 6.82M | 6.73M | 6.84M | 7.77M | 8.57M | 8.64M | 9.31M | 8.84M | 8.52M | 8.75M | 7.91M | 7.63M | 7.44M |
Research & Development | 13.22M | 18.98M | 21.55M | 21.36M | 19.13M | 13.42M | 9.15M | 5.6M | 3.88M | 2.5M | 2.78M | 4.47M | 5.29M | 6.32M | 6.55M | 22.33M | 22.2M | 20.86M |
Other Expenses | n/a | n/a | n/a | 4K | 4K | 4K | 4K | 10K | 1K | 1K | 1K | -9K | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 20.04M | 25.82M | 28.81M | 28.88M | 26.51M | 20.24M | 15.88M | 12.44M | 11.65M | 11.06M | 11.42M | 13.78M | 14.14M | 14.84M | 15.3M | 30.23M | 29.83M | 28.3M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | 84K | 2.27M | 2.28M | 2.28M | 2.2M | 10.71M | 10.71M | 10.71M | 10.71M | 39K | 45K | 53K |
Selling & Marketing Expenses | 10K | 4K | n/a | -10K | -10K | -4K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 11.86M | 21.95M | 28.83M | 28.89M | 26.52M | 20.25M | 15.89M | 12.44M | 11.65M | 11.06M | 11.42M | 13.78M | 14.14M | 14.84M | 15.3M | 30.23M | 29.83M | 28.3M |
Income Tax Expense | 39.28K | 39.28K | n/a | -39.28K | -40.28K | -40.28K | -1K | -5.67M | -5.66M | -5.66M | -5.66M | 7K | -2K | -7K | -12K | -12K | -12K | -5K |
Shares Outstanding (Basic) | 15.29M | 10.26M | 77.57M | 10.21M | 5.43M | 5.09M | 5.08M | 5.08M | 5.06M | 5.06M | 3.18M | 888.69K | 888.69K | 888.69K | 742.85K | 742.81K | 733.34K | 720.52K |
Shares Outstanding (Diluted) | 15.29M | 10.26M | 77.57M | 10.21M | 5.43M | 5.09M | 5.08M | 5.08M | 5.06M | 5.06M | 3.18M | 888.69K | 888.69K | 888.73K | 742.85K | 742.81K | 733.34K | 90.06K |
EPS (Basic) | -1.01 | -2.6 | -3.56 | -4.77 | -4.97 | -3.27 | -2.46 | -1.1 | -3.86 | -7.43 | -10.16 | -16.63 | -17.78 | -19.41 | -52.17 | -81.64 | -122.58 | -153.23 |
EPS (Diluted) | -1.01 | -2.6 | -3.56 | -4.77 | -4.97 | -3.27 | -2.46 | -1.1 | -3.86 | -7.43 | -10.15 | -16.62 | -17.77 | -19.4 | -52.17 | -81.64 | -122.58 | -153.23 |
EBITDA | -19.59M | -25.37M | -28.36M | -25.46M | -23.09M | -16.82M | -12.46M | -12.79M | -12M | -11.41M | -11.76M | -13.74M | -14.1M | -14.79M | -15.25M | -30.19M | -29.78M | -28.25M |
EBIT | 16.96M | 6.88M | n/a | -25.48M | -23.11M | -16.83M | -12.47M | -12.7M | -11.91M | -11.33M | -11.68M | -13.78M | -14.14M | -14.84M | -15.3M | -30.23M | -29.83M | -28.3M |
Depreciation & Amortization | -10K | -4K | n/a | 19K | 15K | -3.06M | -3.07M | -3.07M | -3.07M | 11K | 22K | 33K | 43K | 48K | 48K | 48K | 47K | 47K |